Total Funding
21
8
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
26221
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Aviv Regev: Co-FounderPast Role: Broad Institute, Director of the Klarman Cell Observatory and Cell Circuits Program
Jeffrey Bluestone: Co-founderPast Role: Sonoma Biotherapeutics, CEO and Co-Founder
About the Company
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. The company is a group of scientists, technologists, computational biologists, clinicians, and drug hunters who use single-cell genomics and machine learning analysis to find new drugs.
Celsius Therapeutics was founded in
2018 and is headquartered in Cambridge, Massachusetts.
Women Founded
